Thursday, March 7, 2019

Oncternal Therapeutics Acquires GTx

San Diego-based Oncternal Therapeutics, a privately held biotechnology companies focused on developing therapeutics candidates for cancer, and GTx said this morning that they are in a deal where Oncternals's stockholders will become the majority owners of GTx. GTx is a publicly listed, biopharmaceutical company focused on the discovery, developm

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.